Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na +]i associated with insulin secretion in pancreatic β-cells

American Journal of Physiology - Endocrinology and Metabolism

Volumn 285, Issue 5 48-5, 2003, Pages

  Miura, Yoshikazu ^a   Matsui, Hisao ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Cyclic adenosine 5 monophosphate; Cytosolic Ca2+; Cytosolic Na+; Hamster; Pancreatic islet cells

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; ADENYLATE CYCLASE; BENZOFURAN DERIVATIVE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC AMP DERIVATIVE; FURA 2; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; ISOPHTHALIC ACID; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SODIUM ION;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; HAMSTER; INSULIN RELEASE; MALE; MEMBRANE PERMEABILITY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SODIUM CELL LEVEL;

EID: 0142084673     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00005.2003     Document Type: Article

References (56)

1. Ali L, Grapengiesser E, Gylfe E, Hellman B, and Lund PE. Free and bound sodium in pancreatic β-cells exposed to glucose and tolbutamide. Biochem Biophys Res Commun 164: 212-218, 1989.
2. Bode HP, Moormann B, Dabew R, and Göke B. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic β-cells independently of protein kinase A. Endocrinology 140: 3919-3927, 1999.
3. ATP current in intact mouse pancreatic B-cells. Biochem Biophys Res Commun 207: 33-39, 1995.
4. Cobbold PH and Rink TJ. Fluorescence and bioluminescence measurement of cytoplasmic free calcium. Biochem J 248: 313-328, 1987.
5. + channel in mouse pancreatic β-cells. Exp Physiol 86: 331-339, 2001.
6. Enserink JM, Christensen AE, de Rooij J, Triest MV, Schwede F, Genieser HG, Doskeland SO, Blank JL, and Bos JL. A novel Epac-spesific cAMP analogue demonstrates independent regulation of Rapl and ERK. Nat Cell Biol 4: 901-906, 2002.
7. + to the insulinotropic action of PACAP38 in HIT-T15 cells. J Biol Chem 273: 32602-32607, 1998.
8. (7-36) amide-stimulated insulin secretion in rat islets is sodium-dependent. Biochem Biophys Res Commun 179: 701-706, 1991.
9. (7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action. Diabetes Res 16: 185-191, 1991.
10. 2+-concentration in rat islet cells. Mol Cell Endocrinol 96: 85-90, 1993.
11. 7-36 amide: influences on basal and stimulated insulin and glucagon secretion in the mouse. Pancreas 6: 208-215, 1991.
12. Fujimoto K, Shibasaki T, Yokoi N, Kashima Y, Matsumoto M, Sasaki T, Tajima N, Iwanaga T, and Seino Piccolo S. A Ca2+ sensor in pancreatic β-cells. Involvement of cAMP-GFFII-Rim2-Piccolo complex in cAMP-dependent exocytosis. J Biol Chem 277: 50497-50502, 1992.
13. + in mouse pancreatic β-cells. FEBS Lett 315: 353-356, 1993.
14. Göke R, Fehmann HC, and Göke B. Glucagon-like peptide-1 (7-36) amide is a new incretin/enterogastrone candidate. Eur J Clin Invest 21: 135-144, 1991.
15. + entry into glucose-stimulated pancreatic β-cells after partial inhibition of the Na/K pump. Endocrinology 139: 3227-3231, 1998.
16. Gregersen S, Thomsen JL, and Hemansen K. Endothelin-1 (ET-1)-potentiated insulin secretion: involvement of protein kinase C and the ETA receptor subtype. Metabolism 49: 264-269, 2000.
17. Gromada J, Dissing S, Brokvist K, Renström E, Frøkjæ r-Jensen J, Wulft BS, and Rorsman P. Glucagon-like peptide 1 increases cytoplasmic calcium in insulin-secreting βTC3-cells by enhancement of intracellular calcium mobilization. Diabetes 44: 767-774, 1995.
18. Gromada J, Holst JJ, and Rorsman P. Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflügers Arch 435: 583-594, 1998.
19. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
20. Gutniak M, Ørskov C, Holst JJ, Ahrén B, and Efendic S. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med 326: 1316-1322 1992.
21. Henquin JC. D-Glucose inhibits potassium efflux from pancreatic islet cells. Nature 271: 271-273, 1978.
22. Henquin JC, Garcia MC, Bozem M, Hermans MP, and Nenquin M. Muscarinic control of pancreatic B cell function involves sodium-dependent depolarization and calcium influx. Endocrinology 122: 2134-2142, 1988.
23. Henquin JC and Meissner HP. The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinology 115: 1125-1134, 1984.
24. Holz IVGG, Kühtreiber WM, and Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7-37). Nature 361: 362-365, 1993.
25. 2+-signaling pathway in pancreatic β-cells by the insulinotropic hormone glucagon-like peptide-1. J Biol Chem 270: 17749-17757, 1995.
26. Hurst RD and Morgan NG. Evidence for differential effects of noradrenaline and somatostatin on intracellular messenger systems in rat islets of Langerhans. J Mol Endocrinol 4: 231-237, 1990.
27. Kang G, Joseph JW, Chepurny OG, Monaco M, Wheeler MB, Bos JL, Schwede F, Genieser HG, and Holz GG. Epac-selective cAMP analog 8-pCPT-2′-O-Me-cAMP as a stimulus for Ca2+-induced Ca2+ release and exocytosis in pancreatic β-cells. J Biol Chem 278: 8279-8285, 2003.
28. +-dependent manner. Regul Pept 62: 23-27, 1996.
29. + concentration of rat pituitary cells in primary culture. Endocrinology 138: 5096-5100, 1997.
30. + current in the primary cultured rat somatotroph. J Neuroendocrinol 11: 795-800, 1999.
31. Kreymann B, Ghatei MA, Williams G, and Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2: 1300-1304, 1987.
32. Leech CA and Habener JF. Insulinotropic glucagon-like peptide-1-mediated activation of non-selective cation currents in insulinoma cells is mimicked by maitotoxin. J Biol Chem 272: 17987-17993, 1997.
33. 2+-sensitive nonselective cation channels in regulating the membrane potential of pancreatic β-cells. Diabetes 47: 1066-1073, 1998.
34. 2+ pools. Biochem Biophys Res Commun 224: 67-73, 1996.
35. 2+ response to glucose and gastric inhibitory polypeptide in pancreatic β-cells from triphenyltin-induced diabetic hamster. Endocrinology 138: 2769-2775, 1997.
36. 2+ entry in mouse pancreatic β-cells by both direct and indirect mechanisms. J Physiol 503: 387-398, 1997.
37. 2+ response to glucose and acetylcholine in pancreatic β-cells from hamster. Toxicol Appl Pharmacol 174: 1-9, 2001.
38. Morgan CR and Lazarow A. Immunoassay of insulin: Two antibody system, plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12: 115-126, 1963.
39. Narahashi T, Moode JW, and Scott WR. Tetrodotoxin block-age of sodium conductance increase in lobster giant axons. J Gen Physiol 47: 965-974, 1964.
40. Nathan DM, Schreiber E, Fogel H, Mojsov S, and Habener JF. Insulinotropic action of glucagonlike peptide-1-(7-37) in diabetic and nondiabetic subjects. Diabetes Care 15: 270-276, 1992.
41. Nauck MA, Holst JJ, Willms B, and Schmiegel W. Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes. Exp Clin Endocrinol Diabetes 105: 187-195, 1997.
42. Nelson TY, Gaines KL, Rajan AS, Berg M, and Boyd AE III. Increased cytosolic calcium: a signal for sulfonylurea-stimulated insulin release from beta cells. J Biol Chem 262: 2608-2612, 1987.
43. Okeda T, Ono J, Takaki R, and Todo S. Simple method for the collection of pancreatic islets by the use of Ficoll-Conray gradient. Endocrinol Japon 26: 495-499, 1979.
44. Ørskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35: 701-711, 1992.
45. Ørskov C, Holst JJ, and Nielsen OV. Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107) amide] on endocrine secretion from pig pancreas, antrum, and nonantral stomach. Endocrinology 123: 2009-2013, 1988.
46. Rasmussen H, Zawalich KC, Ganesan S, Calle R, and Zawalich WS. Physiology and pathophysiology of insulin secretion. Diabetes Care 13: 655-666, 1990.
47. + in pancreatic β-cells. Biochim Biophys Acta 1265: 209-212, 1995.
48. + in pancreatic islets exposed to ouabain. Eur J Pharmacol 258: 145-149, 1994.
49. Schmidt WE, Siegel EG, and Creutzfeldt W. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 28: 704-707, 1985.
50. Sussman KE, Leitner JW, and Draznin B. Cytosolic free-calcium concentrations in normal pancreatic islet cells. Effect of secretagogues and somatostatin. Diabetes 36: 571-577, 1987.
51. Takaki R and Ono J. Preparation and culture of isolated islets and dissociated islet cells from rodent pancreas. J Tiss Cult Methods 9: 61-66, 1985.
52. Thorens B. Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide-1. Proc Natl Acad Sci USA 89: 8641-8645, 1992.
53. Turcato S and Clapp LH. Effects of the adenylyl cyclase inhibitor SQ-22536 on iloprost-induced vasorelaxation and cyclic AMP elevation in isolated guinea-pig aorta. Br J Pharmacol 126: 845-847, 1999.
54. 2+ channel activity. Endocrinology 133: 1685-1692, 1993.
55. Yang XC and Sachs F. Block of stretch-activated ion channels in Xenopus oocytes by gadolinium and calcium ions. Science 243: 1068-1071, 1989.
56. Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, and Boyd AE III. Functional expression of the rat glucagon-like peptide-1 receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 133: 57-62, 1993.